Positive News SentimentPositive NewsNASDAQ:SRTA Strata Critical Medical (SRTA) Stock Price, News & Analysis $5.42 +0.14 (+2.56%) Closing price 03:59 PM EasternExtended Trading$5.37 -0.04 (-0.76%) As of 04:13 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock About Strata Critical Medical Stock (NASDAQ:SRTA) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get SRTA alerts:Sign Up Key Stats Today's Range$5.29▼$5.4550-Day Range$5.01▼$6.4752-Week Range$3.67▼$6.50Volume514,592 shsAverage Volume954,477 shsMarket Capitalization$468.56 millionP/E RatioN/ADividend YieldN/APrice Target$8.00Consensus RatingModerate Buy Company Overview Blade Air Mobility, Inc. provides air transportation alternatives to the congested ground routes in the United States. It provides its services through charter and by-the-seat flights using helicopters, jets, turboprops, and amphibious seaplanes. The company was founded in 2014 and is headquartered in New York, New York. Read More Strata Critical Medical Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks67th Percentile Overall ScoreSRTA MarketRank™: Strata Critical Medical scored higher than 67% of companies evaluated by MarketBeat, and ranked 69th out of 134 stocks in the transportation sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.6 / 5Analyst RatingModerate Buy Consensus RatingStrata Critical Medical has received a consensus rating of Moderate Buy. The company's average rating score is 2.75, and is based on 1 strong buy rating, 1 buy rating, 2 hold ratings, and no sell ratings.Upside PotentialStrata Critical Medical has a consensus price target of $8.00, representing about 48.3% upside from its current price of $5.40.Amount of Analyst CoverageStrata Critical Medical has only been the subject of 1 research reports in the past 90 days.Read more about Strata Critical Medical's stock forecast and price target. Earnings and Valuation0.0 / 5Proj. Earnings GrowthN/A Price to Earnings Ratio vs. the MarketThe P/E ratio of Strata Critical Medical is -67.44, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Strata Critical Medical is -67.44, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioStrata Critical Medical has a P/B Ratio of 1.68. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Short Interest4.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted5.57% of the float of Strata Critical Medical has been sold short.Short Interest Ratio / Days to CoverStrata Critical Medical has a short interest ratio ("days to cover") of 2.51, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Strata Critical Medical has recently decreased by 47.92%, indicating that investor sentiment is improving significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldStrata Critical Medical does not currently pay a dividend.Dividend GrowthStrata Critical Medical does not have a long track record of dividend growth. News and Social Media3.8 / 5News Sentiment1.11 News SentimentStrata Critical Medical has a news sentiment score of 1.11. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.75 average news sentiment score of Transportation companies.News Coverage This WeekMarketBeat has tracked 3 news articles for Strata Critical Medical this week, compared to 2 articles on an average week.Search InterestOnly 4 people have searched for SRTA on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.MarketBeat Follows1 people have added Strata Critical Medical to their MarketBeat watchlist in the last 30 days. Company Ownership1.8 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, Strata Critical Medical insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $687,184.00 in company stock.Percentage Held by Insiders15.50% of the stock of Strata Critical Medical is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions47.36% of the stock of Strata Critical Medical is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Strata Critical Medical's insider trading history. Receive SRTA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Strata Critical Medical and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. SRTA Stock News HeadlinesStrata Critical Medical: A Better Alternative To TransMedics In Organ Transplant LogisticsJuly 7, 2026 | seekingalpha.comStrata Critical Medical Inc. - Ordinary Shares - Class AJune 27, 2026 | money.usnews.comThe window is closingWe printed 1,000 copies of this report and 688 are gone—when the last one goes out, we're pulling it offline because the information inside is too sensitive to leave up indefinitely. Inside the remaining copies is the executive order Trump can sign tomorrow, the same legal authority FDR used in 1934 to move billions in wealth overnight, and exactly how to position before it happens.July 15 at 1:00 AM | American Alternative (Ad)Strata Acquires Heart and Lung Transplant National Recovery Program, Expanding National Organ Recovery PlatformJune 24, 2026 | globenewswire.comStrata Critical Medical Insiders Make Bold Moves With Major Stock SalesJune 10, 2026 | tipranks.comStrata Critical Medical shareholders back directors and governance itemsJune 3, 2026 | tipranks.comStrata Acquires Louisville Perfusion ServicesJune 2, 2026 | globenewswire.comHow The Story Is Shifting For Strata Critical Medical (SRTA) After New Analyst AssumptionsMay 25, 2026 | finance.yahoo.comSee More Headlines SRTA Stock Analysis - Frequently Asked Questions How have SRTA shares performed this year? Strata Critical Medical's stock was trading at $4.38 on March 25, 2026. Since then, SRTA stock has increased by 23.2% and is now trading at $5.3950. How were Strata Critical Medical's earnings last quarter? Strata Critical Medical (NASDAQ:SRTA) issued its earnings results on Wednesday, May, 6th. The company reported $0.03 EPS for the quarter, beating analysts' consensus estimates of ($0.04) by $0.07. The business had revenue of $67.38 million for the quarter. Strata Critical Medical had a net margin of 20.56% and a negative trailing twelve-month return on equity of 4.06%. Who are Strata Critical Medical's major shareholders? Top institutional investors of Strata Critical Medical include Allied Private Wealth LLC (0.01%). Insiders that own company stock include Melissa M Tomkiel, William A Heyburn and Amir Cohen. View institutional ownership trends. How do I buy shares of Strata Critical Medical? Shares of SRTA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Last Earnings5/06/2026Today7/15/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Green Zone (3m+) 1-Year History Jul 25 Oct 25 Jan 26 Apr 26 Jul 26 SRTA's financial health is in the Green zone, according to TradeSmith. SRTA has been in this zone for over 3 months. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorTransportation Industry Air Transportation Sub-IndustryTransportation Current SymbolNASDAQ:SRTA CIK1779128 WebN/A Phone(212) 967-1009FaxN/AEmployees130Year FoundedN/APrice Target and Rating Average Price Target for Strata Critical Medical$8.00 High Price Target$8.00 Low Price Target$8.00 Potential Upside/Downside+48.0%Consensus RatingModerate Buy Rating Score (0-4)2.75 Research Coverage4 Analysts Profitability EPS (Trailing Twelve Months)($0.08) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$41.35 million Net Margins20.56% Pretax Margin-7.02% Return on Equity-4.06% Return on Assets-3.49% Debt Debt-to-Equity RatioN/A Current Ratio5.93 Quick Ratio5.93 Sales & Book Value Annual Sales$197.14 million Price / Sales2.37 Cash FlowN/A Price / Cash FlowN/A Book Value$3.22 per share Price / Book1.68Miscellaneous Outstanding Shares86,530,000Free Float73,115,000Market Cap$467.69 million OptionableN/A Beta2.22 7 Best Space Stocks to Own in 2026The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.Get This Free Report This page (NASDAQ:SRTA) was last updated on 7/15/2026 by MarketBeat.com Staff. From Our PartnersTrump's gold order: the announcement they won't put on the front pageOn August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredIran's New Leader Just Said Something That Should Terrify Every AmericanIran's Supreme Leader has declared the Strait of Hormuz closed as leverage against the U.S. - and with 40% of ...American Alternative | SponsoredLouis Navellier: My #1 AI stock for 2026 (name & ticker inside)Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...InvestorPlace | SponsoredThe $15 Gold Fund That Pays Up to $1,152/MonthGold is hitting record highs, but most investors are leaving income on the table. A $15 fund is quietly paying...Investors Alley | SponsoredTrump Takes Emergency Action - Plus Elon Musk's New VentureElon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...Altimetry | SponsoredDOJ Admits It In Court—Your Cash Can Be Seized Without WarningThe Department of Justice recently argued in court that cash may not be legally your property - raising concer...Priority Gold | SponsoredYour $29.97 book is free todayWhy Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options ca...Profits Run | SponsoredSPCX Warning - and Worst News for Stocks in 50 YearsGoldman Sachs and Morgan Stanley are now predicting what could be the worst news for the U.S. stock market in ...TradeSmith | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Strata Critical Medical Please log in to your account or sign up in order to add this asset to your watchlist. Share Strata Critical Medical With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.